CBS 2019
CBSMD教育中心
中 文

科学研究

Abstract

Recommended Article

An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA /ASH/ ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines When high‐volume PCI operators in high‐volume hospitals move to lower volume hospitals—Do they still maintain high volume and quality of outcomes? Coronary flow velocity reserve predicts adverse prognosis in women with angina and noobstructive coronary artery disease: resultsfrom the iPOWER study Macrophage MST1/2 Disruption Impairs Post-Infarction Cardiac Repair via LTB4 Effect of Aspirin on All-Cause Mortality in the Healthy Elderly Mortality 10 Years After Percutaneous or Surgical Revascularization in Patients With Total Coronary Artery Occlusions

JOURNAL:南京心血管医院 Article Link

中美医院管理与改革论坛

CBSMD

尊敬的各位专家和同道 ,


    为提升医院管理水平,推进医院改革,提高医疗质量, 深入中美医疗合作。南京市第一医院、南京市心血管病医院、南京医科大学附属南京医院、南京医院协会将于2018年4月12日(星期四)在古城南京联合主办“中美医院管理与改革论坛(Sino-American Forum of Hospital Management and Reform)”。


时间 4月12日,8:30-18:00

地点 南京市第一医院门诊9楼多功能厅



    本届中美医院管理与改革论坛将围绕“ 医疗体系改革、医疗保健、质量优化、心脑血管疾病的防控、临床试验分析、科学研究现状与展望” 等主题展开研讨。通过探讨医疗改革进程、临床试验、专题病例分析等精彩的学术活动,为医界同仁搭建学术交流共享平台。

    我们诚挚期待您的加入! 愿中西思想碰撞之美为两国医疗系统做出新的贡献!愿我们一同为促进人类健康事业发展贡献绵薄之力!



大会主席 张颖冬 大会执行主席 陈绍良